 |
 | | Criteria for medicinal drug promotion (WHO, 1988, 8 p.) |
| | Guidelines for good clinical practice (GCP) for trials on pharmaceutical products (WHO Technical Report Series, No. 850, 1995, Annex 3) (WHO, 1995, 36 p.) |
| | The TRIPS Agreement and pharmaceuticals (Directorate General of Drug and Food Control - Indonesia - WHO, 2000, 91 p.) |
| | The use of essential drugs: Eight report of the WHO Expert Committee (WHO, 1998, 84 p.) |
| | WHO Drug Information Vol 13 No. 4, 1999 (WHO, 1999, 83 p.) |
| | WHO Drug Information Vol 14 No. 1, 2000 (WHO, 2000, 81 p.) |
| | WHO Drug Information Vol 14 No. 2, 2000 (WHO, 2000, 73 p.) |
| | WHO Drug Information Vol 14 No. 3, 2000 (WHO, 2000, 71 p.) |
| | WHO Policy Perspective on Medicines - No. 1. WHO Medicines Strategy: 2000 - 2003 (WHO, 2000, 6 p.) |
| | WHO Policy Perspective on Medicines - No. 3. Globalization, TRIPS and access to pharmaceuticals (WHO, 2001, 6 p.) |
|
